K-pop

Lisenne’s Agency Announces, “We Are Accepting Reports of Malicious Comments”… Launches Dedicated Reporting Site

Strengthening Measures Against Malicious Posts and False Defamation Promise of Swift Action Based on Fan Reports

YUN GI BACK
2026-07-17 14:24:16
[Edaily Starin YUN GI BACK Reporter] The Muse Entertainment, the agency representing the group RESCENE, has taken steps to protect its artists’ rights by establishing a dedicated reporting channel to address malicious posts and copyright infringement.
RESCENE (Photo courtesy of The Muse Entertainment)

On the 16th, The Muse Entertainment announced via its official website, “We have launched a reporting site to protect RESCENE’s rights and interests.”
According to the agency, the site was created to receive reports from fans regarding malicious posts that defame the artists and instances of copyright infringement, enabling the agency to respond more swiftly and accurately.
The agency stated, “We ask for your active reports to help protect the artist’s rights,” adding, “We will continue to do our best to safeguard the rights of our artists.”
Analysts suggest this measure is closely tied to Lisenne’s rising popularity. This year, Lisenne topped the Top 100 chart on Melon, South Korea’s largest music streaming site, with “LOVE ATTACK,” drawing attention from music fans both domestically and internationally. The group has rapidly expanded its fanbase by generating buzz across various online platforms and short-form content. As her popularity grows, so do instances of online harm—such as malicious posts, the spread of false information, and unauthorized use of content—leading the agency to establish a more proactive response system.

Economy

Corporation

IT·Science

Economy

[VC’s Pick] “Humans and Robots Working Together”… Holiday Robotics Secures Investment

This week (July 13–16), startups across various sectors—including beauty brands, chat platforms, and AI-based decision-making and data infrastructure—secured investments from venture capital (VC) firm…
2026-07-18 12:08:04

Corporation

[Clinical Update] Celltrion Receives Approval for Phase 1 Trial of Tremfya Biosimilar ‘CT-P68’ in South Korea

Here are the clinical trial and product approval updates that garnered attention in the domestic pharmaceutical and biotech industry this week (July 13–16). (Photo: AI-generated) CelltrionRece…
2026-07-18 07:01:02

IT·Science

PharmaResearch, Equipped with U.S.-Based CG USA, Accelerates Expansion into the U.S. ... What Is the Strategy for Reaching 1 Trillion Won in Sales?

PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …
2026-07-17 08:36:02